Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation

Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation

Background: Rheumatoid arthritis is a chronic autoimmune disease that primarily causes inflammation, pain and stiffness in the joints. People with severe disease may be treated with biological disease-modifying anti-rheumatic drugs, including tumour necrosis factor-α inhibitors, but the efficacy of...

Full description

Bibliographic Details
Main Authors: Irina A Tikhonova, Huiqin Yang, Segun Bello, Andrew Salmon, Sophie Robinson, Mohsen Rezaei Hemami, Sophie Dodman, Andriy Kharechko, Richard C Haigh, Meghna Jani, Timothy J McDonald, Martin Hoyle
Format: Article
Language:English
Published: NIHR Journals Library 2021-02-01
Series:Health Technology Assessment
Subjects:
adalimumab
etanercept
infliximab
certolizumab pegol
golimumab
tumour necrosis factor-alpha
cost-effectiveness analysis
cost-utility analysis
drug monitoring
decision tree
antibodies
rheumatoid arthritis
enzyme-linked immunosorbent assay
biologic
biomarker
Online Access:https://doi.org/10.3310/hta25080

Internet

https://doi.org/10.3310/hta25080

Similar Items